Conmed (CNMD) Tops Q2 EPS by 88c
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $46.93 --0%
Revenue Growth %: -0.9%
Financial Fact:
Selling and administrative expense: 79.01M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -0.9%
Financial Fact:
Selling and administrative expense: 79.01M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q2 EPS of ($0.07), $0.88 better than the analyst estimate of ($0.95). Revenue for the quarter came in at $157.8 million versus the consensus estimate of $126.59 million.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler lists 5 chip stocks to buy
- Labcorp sets long-term growth targets at investor day
- Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
